Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-06-13

Clinical Trial Update: Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

View source ↗

Summary

The document describes a clinical trial exploring whether serum IGF-II can be used to monitor and screen for cervical cancer. It lists Onconix, Inc. as sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Onconix, Inc | Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia II | Status: UNKNOWN